Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 2012

View Archived Issues

Researchers present new mGlu2 receptor modulators

Medivir and Janssen team up to develop new agents for hepatitis

Nektar Therapeutics designs novel polymer-G-CSF conjugates

New fatty acid synthase inhibitors patented by GlaxoSmithKline

Scientists at Callidus Biopharma patent new proteins for lysosomal storage disorders

MABEL dose set for NKG2-A-directed monoclonal antibody

ORCA Therapeutics' lead product set to enter clinic

Canadian company discloses novel calcium channel blockers

New thrombin inhibitors generated by Chinese team

Beta Pharma synthesizes new glucokinase activators

New TYK2 inhibitors designed at Cellzome

Fluorinov Pharma obtains funding to support development of FV-162

MMRF awards funding to Modulation Therapeutics for MTI-101

Clinical and preclinical results on tofogliflozin presented at ADA meeting

Palau Pharma sells histamine H4 receptor antagonist

Clinical trials reveal efficacy of albiglutide in treating diabetes

Cinacalcet trial does not meet primary endpoint

MicroBiopharm Japan and Eisai establish collaboration

Sanofi seeks approval for lixisenatide in Japan

Novel results disclosed on GLP-1 receptor agonist ZYOG-1

Canadian government to fund phase II study of lead Edge Therapeutics product

FDA approves Roche antibody for use in combination cancer therapy

Cancer Research UK opens phase Ib/IIa trial of AstraZeneca drug

Approval sought for topical spray against premature ejaculation

Dosing begins in phase III palifosfamide study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...